T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

There is an urgent need to discover blood-based biomarkers to predict response to immune checkpoint inhibitors (ICI). Here the authors show that effective ICI therapy correlates with increased frequency of circulating CX3CR1+CD8+ T cells in preclinical tumor models and in a cohort of patients with n...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood, Sebastiano Battaglia, Saby George, Gurkamal Chatta, Igor Puzanov, Carl Morrison, Kunle Odunsi, Brahm H. Segal, Grace K. Dy, Marc S. Ernstoff, Fumito Ito
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Science
Q
Accès en ligne:https://doaj.org/article/5ad9763c2d134ba4b389bb215a94772a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/5ad9763c2d134ba4b389bb215a94772a

Documents similaires